COVID-19 Study Vaccine

Get Your Patient Form
Clinical Research Partners (7110 Forest Avenue, Suite 201, Richmond, VA 23226)
804-250-9859
Recruitment@ClinicalResearchRVA.com
Get Your Patient Form
Summary
Thestudy vaccine is a modifiedversion of Pfizer-BioNTech’s original mRNA-based COVID-19 vaccine. The updated formulation is designed to improve protection against the latest circulating variant of the COVID-19 virus recommended by the [US Food and Drug Administration (FDA) and] World Health Organization (WHO) for 2025-2026 vaccines. It is currently approved for use in individuals 5 to 64 years of age with at least one underlying condition that puts them at risk of severe outcomes from COVID-19.
Age
5 to 11 Years
Qualifications
  • Have not been diagnosed with COVID-19 recently
  • Have not received a COVID-19 vaccine recently
  • Do not have a history of severe allergic reactions associated with any vaccine
Compensation
Compensation for time and travel may be available.

Meet Our Team

Our experienced team will guide you through the process

Meet the Team

Dr. Call, co-founder of Clinical Research Partners, serves as President. He is a Certified Principle Investigator

Robert S. Call, MD, CPI

President

Annette Bennett, co-founder of Clinical Research Partners, serves as Chief Executive Officer and Research Director. She

Annette Bennett

Chief Executive Officer

Bo Vaughan is a native of Richmond, VA and forward-thinking health care strategist with a

Bo Vaughan, MD, MSHA, CPI

Medical Director

Mimi Franzen Canada

Chief Operations Officer

Jeanette Weller

EVP of Contracts and Budgets

Caitlin Vining

Controller CCRP

Kelly Craighead, BS, RN, CCRC

Regulatory Affairs Director

Carly McLaughlin, PharmD

Director of Pharmacy PharmD

Lisa Smith, BSN, RN

Director of Quality Assurance

Joy Walker

Director of Business Development

Aundraya Bray, LCSW

Clinical Operations Coordinator

Shawn Mease, CCRC, NRP, CCEMT-P

Director of Study Start-Up